BAYLOR COLLEGE OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Urinary Biomarkers of OI Pathobiology
Active, not recruiting
- Conditions
- Osteogenesis Imperfecta
- First Posted Date
- 2015-08-24
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 25
- Registration Number
- NCT02531087
- Locations
- 🇨🇦
Shriners Hospital for Children, Montreal, Quebec, Canada
🇺🇸University of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸Oregon Health Science University, Portland, Oregon, United States
Diabetes Strengths Study - Pilot of Provider-delivered Strengths-based Intervention
Not Applicable
Completed
- Conditions
- Type 1 Diabetes
- Interventions
- Behavioral: Diabetes Strengths Study
- First Posted Date
- 2015-07-29
- Last Posted Date
- 2020-02-24
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 172
- Registration Number
- NCT02510664
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Studying Physiological and Anatomical Cerebral Effects of Carbon Dioxide and Tilt
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Other: ambient airOther: 0.5% CO2
- First Posted Date
- 2015-07-10
- Last Posted Date
- 2016-01-13
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 6
- Registration Number
- NCT02493985
Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)
Phase 1
Recruiting
- Conditions
- Myelodysplastic SyndromeAcute Myeloid Leukemia
- Interventions
- Biological: MultiTAA-specific T cells
- First Posted Date
- 2015-07-10
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 44
- Registration Number
- NCT02494167
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸Houston Methodist Hospital, Houston, Texas, United States
Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders
Early Phase 1
Completed
- Conditions
- Rheumatologic DisordersHematologic DisordersOncologic Disorders
- Interventions
- First Posted Date
- 2015-06-29
- Last Posted Date
- 2018-07-11
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT02484053
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Administration of Donor MultiTAA-Specific T Cells for ALL
Phase 1
Completed
- Conditions
- Leukemia, Lymphoblastic (Acute)
- Interventions
- Biological: MultiTAA-specific T cells
- First Posted Date
- 2015-06-19
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 40
- Registration Number
- NCT02475707
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
Study of Na-APR-1 (M74)/Alhydrogel® Co-administered With Na-GST-1/Alhydrogel in Brazilian Adults
Phase 1
Completed
- Conditions
- Hookworm DiseaseHookworm Infection
- Interventions
- Biological: Na-GST-1/Alhydrogel plus GLA-AFBiological: Na-APR-1 (M74)/Alhydrogel plus GLA-AFBiological: Na-APR-1 (M74)/AlhydrogelBiological: Sterile Saline Placebo
- First Posted Date
- 2015-06-19
- Last Posted Date
- 2019-12-03
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 60
- Registration Number
- NCT02476773
- Locations
- 🇧🇷
Americaninhas Vaccine Center, Americaninhas, Minas Gerais, Brazil
Use of Human Milk Cream to Decrease Length of Stay in Extremely Premature Infants
Not Applicable
Active, not recruiting
- Conditions
- Bronchopulmonary Dysplasia
- Interventions
- Dietary Supplement: Cream Supplement group
- First Posted Date
- 2015-06-18
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 210
- Registration Number
- NCT02475434
- Locations
- 🇺🇸
Michigan State University, East Lansing, Michigan, United States
🇺🇸Cook Children's Medical Center, Fort Worth, Texas, United States
🇺🇸Wasatch Neonatal, Orem, Utah, United States
Cap Assisted Colonoscopy Enhances Quality Based Competency in Colonoscopy Among Trainees
Not Applicable
Completed
- Conditions
- Endoscopy, Gastrointestinal
- Interventions
- Device: Distal Attachment Cap
- First Posted Date
- 2015-06-16
- Last Posted Date
- 2020-02-12
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 219
- Registration Number
- NCT02472730
- Locations
- 🇺🇸
Ben Taub Hospital, Houston, Texas, United States
Trial- Dysphagia From ETT or GI Endoscopy
Not Applicable
Withdrawn
- Conditions
- Respiratory ComplicationsDysphagia
- Interventions
- Device: endotracheal tubeDrug: propofolDrug: FentanylDrug: DexamethasoneDrug: OndansetronDrug: sevoflurane, nitrous oxide and oxygen
- First Posted Date
- 2015-06-02
- Last Posted Date
- 2020-03-09
- Lead Sponsor
- Baylor College of Medicine
- Registration Number
- NCT02460055
© Copyright 2025. All Rights Reserved by MedPath